Records containing: Partial Lipodystrophy
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-16Phase II Study of Growth Hormone Inhibition Using Pegvisomant In Severe Insulin Resistance
-
CLINICAL_TRIALS study record update · 2026-01-20MEASuRE: Metreleptin Effectiveness And Safety Registry
-
CLINICAL_TRIALS study record update · 2025-08-29A 12-Month Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With Partial Lipodystrophy
-
CLINICAL_TRIALS study record update · 2025-07-03A 24-Month, Multi-Centre, Open Label Phase IV Post Authorisation Efficacy Study to Evaluate the Efficacy, Safety and Immunogenicity of Daily Subcutaneous Metreleptin Treatment in Patients With Partial Lipodystrophy
-
CLINICAL_TRIALS study record update · 2019-03-05Double-Blind, Placebo-Controlled Trial of Leptin Replacement Therapy in Patients With Lipodystrophy
- Organize your saved records without ads with Plus.